Borrok M Jack, Mody Neil, Lu Xiaojun, Kuhn Megan L, Wu Herren, Dall'Acqua William F, Tsui Ping
Department of Antibody Discovery and Protein Engineering, MedImmune LLC, Gaithersburg, Maryland 20878.
Department of Formulation Sciences, MedImmune LLC, Gaithersburg, Maryland 20878.
J Pharm Sci. 2017 Apr;106(4):1008-1017. doi: 10.1016/j.xphs.2016.12.023. Epub 2017 Jan 3.
Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the C2 domain) can be a reduction in biophysical stability which can correlate with increased aggregation propensity, poor manufacturability, and lower solubility. Herein, we characterize the changes in IgG conformational and colloidal stability when 2 sets of C2 mutations "TM" (L234F/L235E/P331S) and "YTE" (M252Y/S254T/T256E) are combined to generate an antibody format lacking immune receptor binding and exhibiting extended half-life. In addition to significantly lowered thermostability, we observe greater conformational flexibility for TM-YTE in C2, increased self-association, and poorer solubility and aggregation profiles. To improve these properties, we dissected the contributions of individual mutations within TM-YTE on thermostability and substituted destabilizing mutations with new mutations that raise thermostability. One novel combination, FQQ-YTE (L234F/L235Q/K322Q/M252Y/S254T/T256E), had significantly improved conformational and colloidal stability, and was found to retain the same biological activities as TM-YTE (extended half-life and lack of antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activity). Our engineering approach offers a way to improve the developability of antibodies containing Fc mutations while retaining tailored biological activity.
IgG Fc中的多种突变组合已被表征,以调整免疫效应功能或IgG血清持久性,以适应单克隆抗体治疗所需的生物学结果。在Fc(特别是C2结构域)中引入突变的一个意外后果可能是生物物理稳定性降低,这可能与聚集倾向增加、可制造性差和溶解度降低相关。在此,我们表征了将两组C2突变“TM”(L234F/L235E/P331S)和“YTE”(M252Y/S254T/T256E)组合以产生缺乏免疫受体结合并具有延长半衰期的抗体形式时IgG构象和胶体稳定性的变化。除了显著降低的热稳定性外,我们还观察到TM-YTE在C2中的构象灵活性更高、自缔合增加以及溶解度和聚集谱更差。为了改善这些特性,我们剖析了TM-YTE中单个突变对热稳定性的贡献,并用提高热稳定性的新突变取代了不稳定突变。一种新的组合,FQQ-YTE(L234F/L235Q/K322Q/M252Y/S254T/T256E),具有显著改善的构象和胶体稳定性,并被发现保留了与TM-YTE相同的生物学活性(延长半衰期以及缺乏抗体依赖性细胞介导的细胞毒性和补体依赖性细胞毒性活性)。我们的工程方法提供了一种在保留定制生物学活性的同时提高含Fc突变抗体可开发性的方法。